Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Hubertus Schulte

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncogenesis|September 10, 2015
NeuroblastomaJohannes Hubertus Schulte, Angelika Eggert
Frontiers in Oncology|May 7, 2019
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic GangliaLucie Vivancos Stalin, Marco Gualandi, Johannes Hubertus Schulte, et al.
Journal of Visualized Experiments : Jove|December 24, 2010
Production of chick embryo extract for the cultivation of murine neural crest stem cellsKristian Pajtler, Anna Bohrer, Jochen Maurer, et al.
Oncotarget|June 30, 2020
Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicityChia-Lung Yang, André Serra-Roma, Marco Gualandi, et al.
Frontiers in Immunology|March 6, 2023
Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous diseaseJulia Scheiermann, Annette Künkele, Arend von Stackelberg, et al.
Plos One|January 12, 2013
Focal DNA copy number changes in neuroblastoma target MYCN regulated genesCandy Kumps, Annelies Fieuw, Pieter Mestdagh, et al.
Blood Advances|January 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCTClaus-Philipp Maier, Chihab Klose, Christian Martin Seitz, et al.
Klinische Padiatrie|June 5, 2025
Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncogenesis|September 10, 2015
NeuroblastomaJohannes Hubertus Schulte, Angelika Eggert
Frontiers in Oncology|May 7, 2019
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic GangliaLucie Vivancos Stalin, Marco Gualandi, Johannes Hubertus Schulte, et al.
Journal of Visualized Experiments : Jove|December 24, 2010
Production of chick embryo extract for the cultivation of murine neural crest stem cellsKristian Pajtler, Anna Bohrer, Jochen Maurer, et al.
Oncotarget|June 30, 2020
Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicityChia-Lung Yang, André Serra-Roma, Marco Gualandi, et al.
Frontiers in Immunology|March 6, 2023
Case report: HLA-haploidentical HSCT rescued with donor lymphocytes infusions in a patient with X-linked chronic granulomatous diseaseJulia Scheiermann, Annette Künkele, Arend von Stackelberg, et al.
Plos One|January 12, 2013
Focal DNA copy number changes in neuroblastoma target MYCN regulated genesCandy Kumps, Annelies Fieuw, Pieter Mestdagh, et al.
Blood Advances|January 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCTClaus-Philipp Maier, Chihab Klose, Christian Martin Seitz, et al.
Klinische Padiatrie|June 5, 2025
Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Pageof 1